Bergman Jack, Paronis Carol A
McLean Hospital/Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA.
Mol Interv. 2006 Oct;6(5):273-83. doi: 10.1124/mi.6.5.9.
Animal models for human diseases are highly valued for their utility in developing new therapies. Animals have long provided suitable platforms for the development of innovative surgical procedures and for the study of disease states that are relatively easy to produce in otherwise healthy animals, such as diabetes or hypertension. Increasingly, new strains of animals susceptible to common human illnesses are being introduced into medical research, promising new inroads into the treatment of a variety of organic disorders. Despite these advances in model development, psychiatric disorders, by and large, remain among the hardest to induce experimentally, and the search for reasonable animal procedures to study diseases of the mind is an ongoing challenge for experimental biologists. An exception to this limitation, however, comes in the study of drug abuse. Major developments in this area of research over the last several decades have steadily advanced our ability to identify pharmacological, genetic, and environmental determinants that contribute to the development of drug dependence and addictive behavior.
人类疾病的动物模型因其在开发新疗法方面的实用性而备受重视。长期以来,动物为创新外科手术的发展以及相对容易在原本健康的动物身上诱发的疾病状态(如糖尿病或高血压)的研究提供了合适的平台。越来越多易患常见人类疾病的新型动物品系被引入医学研究,有望为治疗各种器质性疾病开辟新途径。尽管在模型开发方面取得了这些进展,但总体而言,精神疾病仍然是最难通过实验诱发的疾病之一,寻找合理的动物实验方法来研究精神疾病对实验生物学家来说仍是一项持续的挑战。然而,这一局限性的一个例外出现在药物滥用的研究中。过去几十年该研究领域的重大进展稳步提升了我们识别导致药物依赖和成瘾行为发展的药理学、遗传学和环境决定因素的能力。